Literature DB >> 8063224

Deficient interleukin 2 dependent proliferation pathway in T lymphocytes from active and inactive ulcerative colitis patients.

L Manzano1, M Alvarez-Mon, J A Vargas, J A Girón, L Abreu, A Fernández-Corugedo, L I Román, F Albarran, A Durántez.   

Abstract

There is increasing evidence that ulcerative colitis is associated with an abnormality of the immune system. Although the aetiology remains unknown, it has been suggested that the immune system of these patients is implicated in the pathogenesis of their disease. T cell function was investigated in ulcerative colitis patients and defective phytohaemagglutinin induced T cell mitogenesis was found. The DNA synthesis induced by stimulation with phorbol esters plus ionophore (ionomycin), however, was normal. These changes cannot be ascribed to either decreased interleukin 2 synthesis or to a defective interleukin 2 receptor expression after cellular activation. Moreover, this defective proliferative response of the T lymphocytes was observed even in the presence of saturated concentrations of exogenous interleukin 2. These results emphasise that the interleukin 2 dependent proliferation pathway is deficient in T lymphocytes from ulcerative colitis patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8063224      PMCID: PMC1374844          DOI: 10.1136/gut.35.7.955

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  28 in total

1.  In vitro testing of immunoresponsiveness in patients with inflammatory bowel disease: prevalence and relationship to disease activity immunoresponsiveness in IBD.

Authors:  J J Lyanga; P Davis; A B Thomson
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

2.  Enterobacterial common antigen-induced lymphocyte reactivity in inflammatory bowel disease.

Authors:  D M Bull; T F Ignaczak
Journal:  Gastroenterology       Date:  1973-01       Impact factor: 22.682

3.  Lymphocyte responses to nonspecific mitogens in inflammatory bowel disease.

Authors:  P Asquith; S C Kraft; R M Rothberg
Journal:  Gastroenterology       Date:  1973-07       Impact factor: 22.682

4.  Inflammatory bowel disease: lymphocytic responses to nonspecific stimulation in vitro.

Authors:  J Aas; A Huizenga; A D Newcomer; R G Shorter
Journal:  Scand J Gastroenterol       Date:  1972       Impact factor: 2.423

5.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

6.  Peripheral blood mononuclear cells from patients with inflammatory bowel disease exhibit normal function in the allogeneic and autologous mixed leukocyte reaction and cell-mediated lympholysis.

Authors:  R P MacDermott; M J Bragdon; R D Thurmond
Journal:  Gastroenterology       Date:  1984-03       Impact factor: 22.682

7.  T-cell abnormalities in inflammatory bowel disease are mediated by interleukin 2.

Authors:  E C Ebert; S H Wright; W H Lipshutz; S P Hauptman
Journal:  Clin Immunol Immunopathol       Date:  1984-11

8.  Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease.

Authors:  C Fiocchi; M L Hilfiker; K R Youngman; N C Doerder; J H Finke
Journal:  Gastroenterology       Date:  1984-04       Impact factor: 22.682

9.  Two distinct factors are required for induction of T-cell growth.

Authors:  E L Larsson; N N Iscove; A Coutinho
Journal:  Nature       Date:  1980-02-14       Impact factor: 49.962

10.  Characterization of the requirements for human T cell mitogenesis by using suboptimal concentrations of phytohemagglutinin.

Authors:  G B Mills; J W Lee; R K Cheung; E W Gelfand
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

View more
  4 in total

1.  Impaired mitogenic response of peripheral blood T cells in ulcerative colitis is not due to apoptosis.

Authors:  M A Pérez-Machado; L M Espinosa; E J de la Madrigal; L Abreu; G M Lorente; M Alvarez-Mon
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

2.  Effect of anti-TNF therapy and vitamin D derivatives on the proliferation of peripheral blood mononuclear cells in Crohn's disease.

Authors:  Maria Stio; Cristina Treves; Maria Martinesi; Giuseppe d'Albasio; Siro Bagnoli; Andrea G Bonanomi
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

3.  Changes of CD8+CD28- T regulatory cells in rat model of colitis induced by 2,4-dinitrofluorobenzene.

Authors:  Wen-Bin Xiao; Yu-Lan Liu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

4.  Cytokines in inflammatory bowel disease.

Authors:  P L Beck; J L Wallace
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.